Loading...
Loading...
Contributors:
Dataset URI:
9857ca36-6141-4911-97ff-41a5533b1b3dThe primary objective was to compare the bronchodilator efficacy of two doses (5 mcg and 10 mcg) of tiotropium inhalation solution delivered by the Respimat inhaler once daily to placebo and to ipratropium bromide MDI four times daily in patients with COPD. The secondary objective was to compare the safety of tiotropium inhalation solution delivered by the Respimat to placebo and ipratropium bromide MDI.
Keyword(s):
10 mcg once daily tiotropium inhalation solution delivered by the Respimat inhaler; 5 mcg once daily tiotropium inhalation solution delivered by the Respimat inhaler; Chronic Obstructive Pulmonary Disease; Ipratropium Bromide; Placebo.
MeSH Term(s):
Grants and Funding:
Associated Publication(s):
No Associated Publication Data Available
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
No Related Dataset Data Available
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)